Skip to main content
OpenTrials
Completed

NCT Number: NCT07117071

Prevalence of Fuchs Endothelial Corneal Dystrophy in a Population of Dermatology Patients.

The prevalence of Fuchs Endothelial Corneal Dystrophy (FECD) varies from 3.7 to 21.6% of adults depending on the population studied (country and age class), the method of diagnosis and the definition adopted. In the absence of available data for France, we analyzed the prevalence of Fuchs Endothelial Corneal Dystrophy (FECD) in a specific sub-population.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Fuchs Endothelial Corneal Dystrophy Carcinoma Congenital, Hereditary, and Neonatal Diseases and Abnormalities Corneal Diseases Corneal Dystrophies, Hereditary Eye Diseases Eye Diseases, Hereditary Fuchs' Endothelial Dystrophy Genetic Diseases, Inborn Neoplasms Neoplasms by Histologic Type Neoplasms, Glandular and Epithelial

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Saint-Etienne

Saint-Etienne, France

About this study

The Primary purpose is to Estimate the prevalence of Fuchs' endothelial dystrophy in the French population in dermatology population.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient with screening of Fuchs endothelial corneal dystrophy

Exclusion criteria

  • Patients under guardianship
  • Patients unable to receive informed consent
  • Patients with anterior segment pathology (declarative) (the eye concerned will not be photographed)

Treatment and study plan

Collection of medical data

Other

collection of medical data : Age, Sex, Previous cataract surgery, Cellularity, Dermatological pathology, results of screening of Fuchs endothelial corneal dystrophy by Specular microscopy

Primary outcomes

  1. Dark spot in specular microscopy

    Time frame: Years: 1

    Dark sport or guttae after specular microscopy in parallel with the dermatological consultation

Secondary outcomes

  1. Prevalence of Fuchs endothelial corneal dystrophy (FECD) as a function of age

    Time frame: Years: 1

    Prevalence of Fuchs endothelial corneal dystrophy (FECD) as a function of age. Data of medical record will be analyzed.

  2. Prevalence of Fuchs endothelial corneal dystrophy (FECD) as a function of gender

    Time frame: Years: 1

    Prevalence of Fuchs endothelial corneal dystrophy (FECD) as a function of gender.

    Data of medical record will be analyzed.

  3. Correlation between Fuchs endothelial corneal dystrophy (FECD) and skin pathology

    Time frame: Years: 1

    Correlation between Fuchs endothelial corneal dystrophy (FECD) and skin pathology.

    Data of medical record will be analyzed.

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne

Other

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Aug 12, 2025
Registry last updated
Aug 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.